Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 5/23/25 → 5/23/27 |
Funding
- Courante Oncology LLC: $2.00
25-LUN-141-SZB-PMC(ZG006US001): A Phase 1 Dose Escalation Study of the Tolerability, Safety, Efficacy and Pharmacokinetics of ZG006 in Patients with Small Cell Lung Cancer
- Hao, Zhonglin (PI)